The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: Additional analysis from the Japan Diabetes Complications Study

Diabetes Care

Volumn 29, Issue 1, 2006, Pages 145-147

  Sone, Hirohito ^a   Tanaka, Sachiko ^b   Ishibashi, Shun ^c   Yamasaki, Yoshimitsu ^d   Oikawa, Shinichi ^e   Ito, Hideki ^f   Saito, Yasushi ^g   Ohashi, Yasuo ^h   Akanuma, Yasuo ⁱ   Yamada, Nobuhiro ^a,j  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

^g CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ INSTITUTE FOR ADULT DISEASES   (Japan)

^j UNIVERSITY OF TSUKUBA   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; METABOLIC SYNDROME X; MORBIDITY; PREDICTION; STROKE; WORLD HEALTH ORGANIZATION; BLOOD; BLOOD PRESSURE; BODY SIZE; CLASSIFICATION; CLINICAL TRIAL; DIABETIC ANGIOPATHY; JAPAN; MULTICENTER STUDY; PATHOPHYSIOLOGY; REPRODUCIBILITY;

BLOOD PRESSURE; BODY SIZE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES; WORLD HEALTH ORGANIZATION;

EID: 33644876506     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.01.06.dc05-1341     Document Type: Article

References (19)

1. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28:1463-1471, 2005
2. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
4. The International Diabetes Federation: The IDF consensus worldwide definition of metabolic syndrome [article online], 2005. Available from http://www.idf.org/webdata/docs/IDF_metasyndrome_definition.pdf. Accessed 10 July 2005
5. Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, Yamashita H, Yajima Y, Ito H, Ohashi Y, Akanuma Y, Yamada N, the JD Study Group: Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res 34:509 -515, 2002
6. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
7. Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julian B, Portilla Cordoba DP: Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. Rev Esp Cardiol 57:507-513, 2004 [article in Spanish]
8. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: Metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 21:52-58, 2004
9. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27:2689-2694, 2004
10. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769-1778, 2005
11. Reynolds K, Muntner P, Fonseca V: Metabolic syndrome: underrated or underdiagnosed? Diabetes Care 28:1831-1832, 2005
12. Jorgensen ME, Borch-Johnsen K: The metabolic syndrome: is one global definition possible? Diabet Med 21:1064-1065, 2004
13. Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27:1182-1186, 2004
14. Mandavilli A, Cyranoski D: Asia's big problem. Nat Med 10:325-327, 2004
15. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D: Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291:2591-2599, 2004
16. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N, the Japan Diabetes Complication Study Group: Obesity and type 2 diabetes in Japanese patients (Letter). Lancet 361:85, 2003
17. Sone H, Yamada N, Mizuno S, Aida R, Ohashi Y: Alcohol use and diabetes mellitus (Letter). Ann Intern Med 141:408-409, 2004
18. Sone H, Yoshimura Y, Ito H, Ohashi Y, Yamada N, the Japan Diabetes Complications Study Group: Energy intake and obesity in Japanese patients with type 2 diabetes (Letter). Lancet 363:248-249, 2004
19. Sone H, Mizuno S, Yamada N: Vascular risk factors and diabetic neuropathy (Letter). N Engl J Med 352:1925-1927, 2005